Literature DB >> 11918248

Penile prosthesis infections.

D K Montague1, K W Angermeier, M M Lakin.   

Abstract

In this retrospective review we looked at infection rates and risk factors in penile prosthesis recipients. Computer registry records of patients implanted with three-piece inflatable prostheses from April 1986 to March 1999 were reviewed. Bacteriological culture report data were obtained from the medical records. There were 491 three-piece inflatable penile prosthesis recipients with follow-up ranging from 1 to 168 months (mean 83). All patients were implanted more than 1 y ago. There were 10 infections in 491 recipients (2.0%). In 285 primary prosthesis recipients there were seven infections (2.5%). In 206 secondary prosthesis recipients there were three infections (1.5%). Seven infections occurred in 354 non-diabetics (2.0%) and three infections occurred in 137 diabetics (2.2%). None of these differences were statistically significant. Explants for infection were performed in 8 weeks or less following implantation in eight patients. In two patients explants occurred at 17 and 26 months following implantation. Cultures from the periprosthetic space grew E. coli (four), Proteus mirabilis (two), Staph. aureus (two), and bacteroides (two). Infections occurred in 2.0% of three-piece inflatable penile prosthesis recipients. There were no statistically significant differences in infection rates between first time and repeat prosthesis recipients and between diabetic and non-diabetic recipients. Eight of the 10 infections occurred 8 weeks or less following implantation.

Entities:  

Mesh:

Year:  2001        PMID: 11918248     DOI: 10.1038/sj.ijir.3900768

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  16 in total

Review 1.  An overview of the diagnosis and treatment of erectile dysfunction.

Authors:  Sivaprakasam Sivalingam; Hashim Hashim; Hartwig Schwaibold
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Penile prosthesis implantation for the treatment for male erectile dysfunction: clinical outcomes and lessons learnt after 955 procedures.

Authors:  E Chung; C T Van; I Wilson; R A Cartmill
Journal:  World J Urol       Date:  2012-03-29       Impact factor: 4.226

Review 3.  A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?

Authors:  Konstantinos Hatzimouratidis; Dimitrios G Hatzichristou
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Infection Prevention Considerations for Complex Penile Prosthesis Recipients.

Authors:  Robert J Carrasquillo; Ricardo M Munarriz; Martin S Gross
Journal:  Curr Urol Rep       Date:  2019-02-01       Impact factor: 3.092

5.  The impact of diabetes mellitus on penile length in men undergoing inflatable penile prosthesis implantation.

Authors:  Yiğit Akın; İlker Fatih Şahiner; Mustafa Faruk Usta
Journal:  Turk J Urol       Date:  2013-09

6.  Trends in penile prosthesis implantation and analysis of predictive factors for removal.

Authors:  Kai Li; Eileen R Brandes; Steven L Chang; Jeffrey J Leow; Benjamin I Chung; Ye Wang; Jairam R Eswara
Journal:  World J Urol       Date:  2018-09-24       Impact factor: 4.226

Review 7.  Current use of penile implants in erectile dysfunction.

Authors:  John J Mulcahy; Steven K Wilson
Journal:  Curr Urol Rep       Date:  2006-11       Impact factor: 2.862

Review 8.  Penile prosthesis coating and the reduction of postoperative infection.

Authors:  Robert Abouassaly; Drogo K Montague
Journal:  Curr Urol Rep       Date:  2004-12       Impact factor: 2.862

9.  The Association Between Hemoglobin A1c Levels and Inflatable Penile Prosthesis Infection: Analysis of US Insurance Claims Data.

Authors:  Tony Chen; Shufeng Li; Michael L Eisenberg
Journal:  J Sex Med       Date:  2021-06-06       Impact factor: 3.937

10.  Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: evaluation of efficacy, satisfaction profile and complications.

Authors:  G Antonini; G M Busetto; E De Berardinis; R Giovannone; P Vicini; F Del Giudice; S L Conti; V Gentile; P E Perito
Journal:  Int J Impot Res       Date:  2015-12-10       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.